Search | Nursing VHL Search Portal

1.

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.

Godfrey, James K; Gao, Lei; Shouse, Geoffrey; Song, Joo Y; Pak, Stacy; Lee, Brian; Chen, Bihong T; Kallam, Avyakta; Baird, John H; Marcucci, Guido; Ghoda, Lucy Y; Vauleon, Stephanie; Danilov, Alexey V; Herrera, Alex F; Kwak, Larry W; Budde, Lihua E.

Blood ; 2024 Mar 14.

Article in English | MEDLINE | ID: mdl-38484137

2.

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.

Zurko, Joanna; Ramdial, Jeremy; Shadman, Mazyar; Ahmed, Sairah; Szabo, Aniko; Iovino, Lorenzo; Tomas, Ana Alarcon; Sauter, Craig; Perales, Miguel-Angel; Shah, Nirav N; Acharya, Utkarsh H; Jacobson, Caron; Soiffer, Robert J; Wang, Trent; Komanduri, Krishna V; Jaglowski, Samantha; Kittai, Adam S; Denlinger, Nathan; Iqbal, Madiha; Kharfan-Dabaja, Mohamed A; Ayala, Ernesto; Chavez, Julio; Jain, Michael; Locke, Frederick L; Samara, Yazeed; Budde, Lihua E; Mei, Matthew G; Pia, Alexandra Della; Feldman, Tatyana; Ahmed, Nausheen; Jacobs, Ryan; Ghosh, Nilanjan; Dholaria, Bhagirathbhai; Oluwole, Olalekan O; Hess, Brian; Hassan, Ayesha; Kenkre, Vaishalee P; Reagan, Patrick; Awan, Farrukh; Nieto, Yago; Hamadani, Mehdi; Herrera, Alex F.

Haematologica ; 108(1): 98-109, 2023 01 01.

Article in English | MEDLINE | ID: mdl-35833303

3.

Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma.

Ong, Shin Yeu; Pak, Stacy; Mei, Matthew; Wang, Yan; Popplewell, Leslie; Baird, John H; Herrera, Alex F; Shouse, Geoffrey; Nikolaenko, Liana; Zain, Jasmine; Godfrey, James; Htut, Myo; Aribi, Ahmed; Spielberger, Ricardo; Mansour, Joshua; Forman, Stephen J; Palmer, Joycelynne; Budde, Lihua E.

Am J Hematol ; 98(11): 1751-1761, 2023 11.

Article in English | MEDLINE | ID: mdl-37668287

4.

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.

Budde, Lihua E; Sehn, Laurie H; Matasar, Matthew; Schuster, Stephen J; Assouline, Sarit; Giri, Pratyush; Kuruvilla, John; Canales, Miguel; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta; Cheah, Chan Yoon; Wei, Michael C; Yin, Shen; Li, Chi-Chung; Huang, Huang; Kwan, Antonia; Penuel, Elicia; Bartlett, Nancy L.

Lancet Oncol ; 23(8): 1055-1065, 2022 08.

Article in English | MEDLINE | ID: mdl-35803286

5.

A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma.

Strati, Paolo; Coleman, Morton; Champion, Rebecca; Ma, Shuo; Patti, Caterina; Levy, Moshe Y; Lossos, Izidore S; Geethakumari, Praveen Ramakrishnan; Lam, Selay; Calvo, Roser; Higgins, Kara; Budde, Lihua E.

Br J Haematol ; 199(1): 76-85, 2022 10.

Article in English | MEDLINE | ID: mdl-35861370

6.

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

Thompson, John A; Schneider, Bryan J; Brahmer, Julie; Achufusi, Amaka; Armand, Philippe; Berkenstock, Meghan K; Bhatia, Shailender; Budde, Lihua E; Chokshi, Saurin; Davies, Marianne; Elshoury, Amro; Gesthalter, Yaron; Hegde, Aparna; Jain, Michael; Kaffenberger, Benjamin H; Lechner, Melissa G; Li, Tianhong; Marr, Alissa; McGettigan, Suzanne; McPherson, Jordan; Medina, Theresa; Mohindra, Nisha A; Olszanski, Anthony J; Oluwole, Olalekan; Patel, Sandip P; Patil, Pradnya; Reddy, Sunil; Ryder, Mabel; Santomasso, Bianca; Shofer, Scott; Sosman, Jeffrey A; Wang, Yinghong; Zaha, Vlad G; Lyons, Megan; Dwyer, Mary; Hang, Lisa.

J Natl Compr Canc Netw ; 20(4): 387-405, 2022 04.

Article in English | MEDLINE | ID: mdl-35390769

7.

Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.

Kim, Won Seog; Oki, Yasuhiro; Kim, Seok Jin; Yoon, Sang Eun; Ardeshna, Kirit M; Lin, Yi; Ruan, Jia; Porcu, Pierluigi; Brammer, Jonathan E; Jacobsen, Eric D; Yoon, Dok Hyun; Suh, Cheolwon; Suarez, Felipe; Radford, John; Budde, Lihua E; Kim, Jin Seok; Bachy, Emmanuel; Lee, Hun Ju; Bollard, Catherine M; Jaccard, Arnaud; Kang, Hye Jin; Inman, Shannon; Murray, Maryann; Combs, Katherin E; Lee, Daniel Y; Advani, Ranjana; Gunter, Kurt C; Rooney, Cliona M; Heslop, Helen E.

Ann Hematol ; 100(10): 2529-2539, 2021 Oct.

Article in English | MEDLINE | ID: mdl-34304287

8.

Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies.

Shah, Nina; Perales, Miguel-Angel; Turtle, Cameron J; Cairo, Mitchell S; Cowan, Andrew J; Saeed, Hayder; Budde, Lihua E; Tan, Alan; Lee, Zachary; Kai, Kazuharu; Marcondes, Mario Q; Zalevsky, Jonathan; Tagliaferri, Mary A; Patel, Krina K.

Future Oncol ; 17(27): 3549-3560, 2021 Sep.

Article in English | MEDLINE | ID: mdl-34154392

9.

Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program.

Dulan, Sylvia O; Viers, Kathie L; Wagner, Jamie R; Clark, Mary C; Chang, Brenda; Gorospe, Gerardo L; Londrc, Adina; Brown, Annette S; Rosenthal, Joseph; Smith, Eileen P; Forman, Stephen J; Snyder, David S; Budde, Lihua E.

Biol Blood Marrow Transplant ; 26(8): 1386-1393, 2020 08.

Article in English | MEDLINE | ID: mdl-32439475

10.

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.

Thompson, John A; Schneider, Bryan J; Brahmer, Julie; Andrews, Stephanie; Armand, Philippe; Bhatia, Shailender; Budde, Lihua E; Costa, Luciano; Davies, Marianne; Dunnington, David; Ernstoff, Marc S; Frigault, Matthew; Kaffenberger, Benjamin H; Lunning, Matthew; McGettigan, Suzanne; McPherson, Jordan; Mohindra, Nisha A; Naidoo, Jarushka; Olszanski, Anthony J; Oluwole, Olalekan; Patel, Sandip P; Pennell, Nathan; Reddy, Sunil; Ryder, Mabel; Santomasso, Bianca; Shofer, Scott; Sosman, Jeffrey A; Wang, Yinghong; Weight, Ryan M; Johnson-Chilla, Alyse; Zuccarino-Catania, Griselda; Engh, Anita.

J Natl Compr Canc Netw ; 18(3): 230-241, 2020 03.

Article in English | MEDLINE | ID: mdl-32135517

11.

Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma.

Othman, Tamer; Baird, John H; Pak, Stacy; Mei, Matthew; Herrera, Alex F; Mansour, Joshua; Shouse, Geoffrey; Sahebi, Firoozeh; Spielberger, Ricardo; Cai, Ji-Lian; Farol, Leonardo; Godfrey, James; Kallam, Avyakta; Phillips, Tycel; Popplewell, Leslie; Siddiqi, Tanya; Forman, Stephen; Budde, Lihua E.

Br J Haematol ; 2024 May 26.

Article in English | MEDLINE | ID: mdl-38797530

12.

Management of Immunotherapy-Related Toxicities, Version 1.2019.

Thompson, John A; Schneider, Bryan J; Brahmer, Julie; Andrews, Stephanie; Armand, Philippe; Bhatia, Shailender; Budde, Lihua E; Costa, Luciano; Davies, Marianne; Dunnington, David; Ernstoff, Marc S; Frigault, Matthew; Hoffner, Brianna; Hoimes, Christopher J; Lacouture, Mario; Locke, Frederick; Lunning, Matthew; Mohindra, Nisha A; Naidoo, Jarushka; Olszanski, Anthony J; Oluwole, Olalekan; Patel, Sandip P; Reddy, Sunil; Ryder, Mabel; Santomasso, Bianca; Shofer, Scott; Sosman, Jeffrey A; Wahidi, Momen; Wang, Yinghong; Johnson-Chilla, Alyse; Scavone, Jillian L.

J Natl Compr Canc Netw ; 17(3): 255-289, 2019 03 01.

Article in English | MEDLINE | ID: mdl-30865922

13.

Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma.

Herrera, Alex F; Rodig, Scott J; Song, Joo Y; Kim, Young; Griffin, Gabriel K; Yang, Dongyun; Nikolaenko, Liana; Mei, Matthew; Bedell, Victoria; Dal Cin, Paola; Pak, Christine; Alyea, Edwin P; Budde, Lihua E; Chen, Robert; Chen, Yi-Bin; Chan, Wing C; Cutler, Corey S; Ho, Vincent T; Koreth, John; Krishnan, Amrita; Murata-Collins, Joyce L; Nikiforow, Sarah; Palmer, Joycelynne; Pihan, German A; Pillai, Raju; Popplewell, Leslie; Rosen, Steven T; Siddiqi, Tanya; Sohani, Aliyah R; Zain, Jasmine; Kwak, Larry W; Weisenburger, Dennis D; Weinstock, David M; Soiffer, Robert J; Antin, Joseph H; Forman, Stephen J; Nademanee, Auayporn P; Armand, Philippe.

Biol Blood Marrow Transplant ; 24(3): 514-520, 2018 03.

Article in English | MEDLINE | ID: mdl-29196080

14.

Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.

Budde, Lihua E; Wu, David; Martin, Daniel B; Philip, Mary; Shustov, Andrei R; Smith, Stephen D; Gooley, Ted A; Chen, Tara L; Libby, Edward N; Chen, Eric Y; Kojouri, Kiarash; Langerak, Alan; Roden, Jennifer E; Press, Oliver W; Gopal, Ajay K.

Br J Haematol ; 183(4): 601-607, 2018 11.

Article in English | MEDLINE | ID: mdl-30596402

15.

Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.

Wang, Xiuli; Popplewell, Leslie L; Wagner, Jamie R; Naranjo, Araceli; Blanchard, M Suzette; Mott, Michelle R; Norris, Adam P; Wong, ChingLam W; Urak, Ryan Z; Chang, Wen-Chung; Khaled, Samer K; Siddiqi, Tanya; Budde, Lihua E; Xu, Jingying; Chang, Brenda; Gidwaney, Nikita; Thomas, Sandra H; Cooper, Laurence J N; Riddell, Stanley R; Brown, Christine E; Jensen, Michael C; Forman, Stephen J.

Blood ; 127(24): 2980-90, 2016 06 16.

Article in English | MEDLINE | ID: mdl-27118452

16.

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma.

Locke, Frederick L; Neelapu, Sattva S; Bartlett, Nancy L; Siddiqi, Tanya; Chavez, Julio C; Hosing, Chitra M; Ghobadi, Armin; Budde, Lihua E; Bot, Adrian; Rossi, John M; Jiang, Yizhou; Xue, Allen X; Elias, Meg; Aycock, Jeff; Wiezorek, Jeff; Go, William Y.

Mol Ther ; 25(1): 285-295, 2017 Jan 04.

Article in English | MEDLINE | ID: mdl-28129122

17.

Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab.

Mei, Matthew G; Cao, Thai M; Chen, Lu; Song, Joo Y; Siddiqi, Tanya; Cai, Ji-Lian; Farol, Leonardo T; Al Malki, Monzr M; Salhotra, Amandeep; Aldoss, Ibrahim; Palmer, Joycelynne; Herrera, Alex F; Zain, Jasmine; Popplewell, Leslie L; Chen, Robert W; Rosen, Steven T; Forman, Stephen J; Kwak, Larry; Nademanee, Auayporn P; Budde, Lihua E.

Biol Blood Marrow Transplant ; 23(11): 1861-1869, 2017 Nov.

Article in English | MEDLINE | ID: mdl-28733266

18.

T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia.

Mardiros, Armen; Forman, Stephen J; Budde, Lihua E.

Curr Opin Hematol ; 22(6): 484-8, 2015 Nov.

Article in English | MEDLINE | ID: mdl-26457961

19.

CD19 CAR-T therapy and sepsis: dancing with the devil.

Budde, Lihua E; Zaia, John A.

Blood ; 131(1): 7-8, 2018 01 04.

Article in English | MEDLINE | ID: mdl-29301772

20.

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.

Till, Brian G; Jensen, Michael C; Wang, Jinjuan; Qian, Xiaojun; Gopal, Ajay K; Maloney, David G; Lindgren, Catherine G; Lin, Yukang; Pagel, John M; Budde, Lihua E; Raubitschek, Andrew; Forman, Stephen J; Greenberg, Philip D; Riddell, Stanley R; Press, Oliver W.

Blood ; 119(17): 3940-50, 2012 Apr 26.

Article in English | MEDLINE | ID: mdl-22308288

Nursing VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: